slide1 l.
Download
Skip this Video
Loading SlideShow in 5 Seconds..
International Society for Pharmacoeconomics and Outcomes Research PowerPoint Presentation
Download Presentation
International Society for Pharmacoeconomics and Outcomes Research

Loading in 2 Seconds...

play fullscreen
1 / 61

International Society for Pharmacoeconomics and Outcomes Research - PowerPoint PPT Presentation


  • 327 Views
  • Uploaded on

International Society for Pharmacoeconomics and Outcomes Research. Chris L Pashos, PhD ISPOR President, 2008-2009. ISPOR SRBIJA. Belgrade, Serbia. WELCOME DOBRODO š LI ISPOR SRBIJA 1 ST INTERNATIONAL CONFERENCE. President Vladimir Zah, K.S. B.Sc., Health Economics Consultant, Belgrade

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'International Society for Pharmacoeconomics and Outcomes Research' - sandra_john


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
slide2

Chris L Pashos, PhD

ISPOR President, 2008-2009

slide6

President

Vladimir Zah, K.S. B.Sc., Health Economics Consultant, Belgrade

Vice-President

Tanja Novakovic, MSc Pharm., Galenika a.d., President of Pharmacoeconomic Section of Pharmaceutical Society of Serbia (FDS), Belgrade

Secretary / Treasurer

Dr sci. ph. spec Natasa Bogavac-Stanojevic, Assoc. Professor, Faculty of Pharmacy, University of Belgrade

slide7

Directors

Dr sci. med. Ana Sabo, Professor, Medical Faculty, University of Novi Sad

Dr Predrag Djukic, Consultant, Project Coordination Unit, Ministry of Health, Belgrade

Dr Dragana Atanasijevic, ConsultantProject Coordination Unit, Ministry of Health, Belgrade

Doc.dr sci.ph Vesela Radonjic, Director, National Information Center for Medicine and Medical Devices (ALIMS), Belgrade

Mr ph Danka Stefanovic, ALIMS, Belgrade

Mr ph Danka Tesic, ALIMS, Belgrade

Mr ph spec. Dragana Sovtic, Independent advisor for pharmaceutical issues, The Pharmaceutical Chamber of Serbia

slide8

ISPOR

An international, educational and scientific organization that fosters excellence in pharmacoeconomics and outcomes research and the appropriate use of resulting information in

health care decisions at all levels

to promote the public health and well-being

slide9

OUR MISSION

To promote the science of

pharmacoeconomics and outcomes research

To facilitate the translation of this research into useful information for health care decision makers

To ensure that society allocates scarce resources wisely, fairly, and efficiently

RESEARCHEVIDENCEDECISIONSHEALTH

slide10

Who we are

  • Where we are going
  • How we will get there
slide11

OUR SCOPE

MULTI-DISCIPLINARY

Decision Analysis, Economics, Epidemiology, Modeling, Patient Reported Outcomes Assessment, Real World Data Analysis, Risk Assessment

INCLUSIVE

Decision Makers, Health Care Providers, Researchers, Students

GEOGRAPHICALLY DIVERSE

who we are13

STUDENT NETWORK

Who We Are

40Student Chapters Worldwide

484Student Members

slide14

Who We Are

ISPOR Membership Including Chapters

who we are15

ISPOR Membership including Chapters

Who We Are

2400 ISPOR CHAPTER MEMBERS

4200

ISPOR

MEMBERS

OVER 6600

WORLDWIDE

who we are16
Who We Are

Asia-Pacific

  • China MDA-PE
  • Hong Kong
  • India
  • Japan
  • Shanghai
  • Taiwan
  • Thailand
  • Australia
  • Under development
  • Malaysia
  • South Korea
  • Pakistan
  • Singapore
who we are17
Who We Are

Latin America

  • Argentina
  • Brazil
  • Chile
  • Colombia
  • Mexico
  • Venezuela
  • Under development
  • Cuba
  • Ecuador
  • Peru
who we are18
Who We Are

Europe – Middle East

  • Belarus
  • Croatia
  • Czech Republic
  • Greece
  • Hungary
  • Poland
  • Russia
  • Serbia
  • Slovakia
  • Turkey
  • Ukraine
  • Israel
  • Jordan
slide21

Who We Are

MEMBERSHIP - WORK ENVIRONMENT

Academia

Research

Groups

Health Care Providers

Medical Technology

Firms

Governments

slide23

Who We Are

MEMBERSHIP – RESEARCH INTERESTS

Methods

PROs

Costs

Clinical Outcomes

Policy

slide24

Who We Are

ISPOR – MOVING AHEAD TOGETHER

slide25

Where We Are Going

Patients (Recipients of Health Care)

Patients

Health Care Providers

FOSTER RESEARCH EXCELLENCE

PROMOTE EDUCATION

Health Care Payers

Health Care

Health Care

Researchers

PROMOTE COLLABORATION WITH DECISION MAKERS

STIMULATE INTERNATIONAL GROWTH

Regulators & Tech Assessors

slide26

What We Do

GLOBAL OUTREACH

slide30

II. Medzinárodná konferencia

ISPOR Slovak Chapter

Zastúpenie Medzinárodnej spoločnosti pre farmakoekonomiku a klinické výstupy (ISPOR) v Slovenskej republike

slide35

What We Do

  • COLLABORATION TO MOVE THE FIELD FORWARD
slide36

What We Do

Special Interest Groups

Initiated by ISPOR members,

formed with a specific research-focused goal.

Task Forces

Formed by the Board of Directors for a specific purpose such as to develop Good Research Practices.

Councils

Advisory bodies to ISPOR & its Board of Directors.

slide37

What We Do

PUBLICATIONS

what we do38

What We Do

PUBLICATIONS

what we do39

What We Do

PUBLICATIONS

F u t u r e B o o k s

what we do41

Tools For Decision-Makers

What We Do

  • Global Health Care System Road Map
  • Pharmacoeconomic Guidelines Around the World
  • Managed Care Outcomes Research Digest
  • ISPOR Comments on Health Policy
what we do42

Global Health Care Systems Road Map

Overview of Country Specific Health Systems and Reimbursement Process

What We Do

what we do43

Managed Care Outcomes Research Digest

Searchable by service provided, outcomes assessed or key word

What We Do

what we do44

Tools For Health Care Researchers

What We Do

  • ISPOR Research Digest
  • Digest of International Databases
  • Good Research Practices
what we do45

ISPOR Research Digest

What We Do

Electronic database ~9000 research studies from ISPOR meetings

what we do46

Digest of International Databases

Directory of Databases searchable by key attributes

What We Do

what we do47

Good Research Practices

What We Do

Published articles and reports on multidisciplinary topics

good research practices
Good Research Practices

What We Do

Code of Ethics

  • Design and Research Practices
  • Sponsorship
  • Publication and Dissemination
  • Relationship with Others
  • Role of ISPOR
good research practices49
Economic/Pharmacoeconomic Methods

Modeling

Budget Impact Analysis

CEA with Clinical Trials

Drug Cost Standards

Economic Data Transferability

Good Research Practices

What We Do

good research practices50
Good Research Practices

What We Do

Patient Reported Outcomes (PRO) Methods

  • PRO Methods and Concepts
  • Quality of Life Methods
  • Preference-based Methods
  • Population-based Methods
  • Application of Conjoint Analysis in Outcomes Research
good research practices51
Good Research Practices

What We Do

Real World Methods & Studies

  • Data-based Methods
  • Disease and Health Management Data & Methods
  • Patient Registry Methods
  • Medication Compliance and Persistence Methods & Studies
  • Risk-Benefit Methods
good research practices52
Good Research Practices

What We Do

Real World Methods & Studies(con’t)

  • Design and Operations of Patient Registries
  • Evaluating Health/Disease Management Programs
  • Patient Registry Classification Strategy & Design
  • Reliability & Validity of Data Sources for Disease & Health Management
good research practices53
Good Research Practices

What We Do

Medical Devices & Diagnostics

Outcomes Research

  • Technology development issues
  • Regulatory requirements
  • Clinical outcomes research
  • Economic outcomes research
  • Patient-reported outcome research
  • Developing evidence & reimbursement issues
health technology assessment activities
HEALTH TECHNOLOGY ASSESSMENT ACTIVITIES

What We Do

HTA & EVIDENCE-BASED DECISIONS

SPECIAL INTEREST GROUP

WORKING GROUPS

  • HTA FOR REIMBURSEMENT DECISIONS
  • HTA OF EMERGING NEW TECHNOLOGIES
  • GLOBAL HTA USED IN HC REIMBURSEMENT
hta activities
HTA ACTIVITIES

What We Do

  • Information
    • Roadmap of global health care delivery & reimbursement systems
    • Directory of HTA organizations worldwide
  • Methods
    • Survey of methods used globally in HTA and policy making
  • Translation
    • Survey of processes for adopting emerging technologies
hta activities56
HTA ACTIVITIES

What We Do

ISPOR HTA Council

KEY ISSUES

  • Need for data
  • HTA scope & technology life cycle
  • Methods
  • HTA prioritization
  • Translating information for or by policy makers
slide57

Where We Are Going

Patients (Recipients of Health Care)

Patients

Health Care Providers

FOSTER RESEARCH EXCELLENCE

PROMOTE EDUCATION

Health Care Payers

Health Care

Health Care

Researchers

PROMOTE COLLABORATION WITH DECISION MAKERS

STIMULATE INTERNATIONAL GROWTH

Regulators & Tech Assessors

slide59
3 C

Collaboration

Collegiality

Communication

(SR)2

Scientific Rigor

Societal Relevance